LSBio
FLT4 / VEGFR3 Antibody (aa1063-1363, clone OTI1G2, Carrier-free)

HEK293T cells were transfected with the pCMV6-ENTRY control. (Left lane) or pCMV6-ENTRY FLT4. (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates. (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FLT4.

FLT4 / VEGFR3 Antibody (aa1063-1363, clone OTI1G2, Carrier-free)

Primary AntibodyLSBio Guarantee
Antibody:Mouse Monoclonal
Applications:Western Blot
Reactivity:Human
Format:Lyophilized
See all Human FLT4 / VEGFR3 antibodies →
$522.00each
Catalog Number: LS-C798342-100

For bulk orders or custom formulations:

Request a Quote

Overview

Description
VEGFR3 antibody LS-C798342 is an unconjugated mouse monoclonal antibody to human VEGFR3 (FLT4) (aa1063-1363). Validated for WB.
Application
WB
Reactivity
Hu
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Monoclonal Antibodies
Alternative Names
FLT4 | FLT41 | Fms-related tyrosine kinase 4 | Fms-like tyrosine kinase 4 | LMPH1A | PCL | Soluble VEGFR3 variant 1 | Vegf-r3 | VEGFR3 | Soluble VEGFR3 variant 2 | Soluble VEGFR3 variant 3 | FLT-4 | Quek2 | VEGF Receptor 3 | VEGFR-3
Recommended Dilution: WB
1:500
UniProt Number
P35916
SwissProt
P35916

Target

Target
Human FLT4 / VEGFR3
Antigen Species
Human
Gene Name
FLT4

Antibody

Host Species
Mouse
Clonality
Monoclonal
Clone
OTI1G2
Isotype
IgG1
Origin Species
Human

Immunogen

Immunogen
Human recombinant protein fragment corresponding to amino acids 1063-1363 of human FLT4(NP_891555) produced in E.coli.
Immunogen Type
Recombinant Protein Fragment

Format

Conjugate/Label
Unconjugated
Format
Lyophilized
Formulation
PBS, pH 7.3, 8% Trehalose
Preservative
No
Purification Method
Other

Storage & Handling

Storage Conditions
Store at -20°C. Avoid freeze-thaw cycles.
Recommended Storage Buffer
PBS

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.